HMS
CLVS

Hanseatic Management Services’s Clovis Oncology, Inc. CLVS Stock Holding History

Hanseatic Management Services’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-2,893
Closed -$238K – 486
2017
Q3 		$238K Sell
2,893
-10,800
-79% -$856K 0.27% 102
2017
Q2 		$1.28M Buy
13,693
+37
+0.3% +$2.26K 0.65% 54
2017
Q1 		$869K Buy
13,656
+13,637
+71,774% +$829K 0.48% 84
2016
Q4 		$1K Hold
19
– – ﹤0.01% 294
2016
Q3 		$1K Buy
+19
New +$408 ﹤0.01% 283
2015
Q4 		– Sell
-8,421
Closed -$774K – 420
2015
Q3 		$774K Buy
+8,421
New +$729K 0.24% 136

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Hanseatic Management Services's CLVS Position: Q4 2017 in Review

Hanseatic Management Services sold out of Clovis Oncology, Inc. (CLVS) in Q4 2017, closing a stake of 2,893 shares — an estimated $238K sold.

Hanseatic Management Services first reported a position in CLVS in Q3 2015 and held it in 6 quarters. The position peaked at $1.28M in Q2 2017. 247 funds tracked by Wall St. Rank hold CLVS as of Q4 2017.

  • Hanseatic Management Services reported no remaining Clovis Oncology, Inc. position as of Q4 2017 after selling out during the quarter.
  • Hanseatic Management Services sold 2,893 Clovis Oncology, Inc. shares in Q4 2017, an estimated $238K.
  • Hanseatic Management Services first reported a position in Clovis Oncology, Inc. in Q3 2015 and held it in 6 quarters.
  • Hanseatic Management Services's Clovis Oncology, Inc. position peaked at $1.28M in Q2 2017.
  • 247 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2017.

Based on Hanseatic Management Services's 13F filing for Q4 2017, filed 14 Feb 2018.